(Q29616112)

English

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

scientific article (publication date: 20 October 2005)

Statements

0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit